GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (NAS:DXCM) » Definitions » Price-to-Owner-Earnings

DexCom (DexCom) Price-to-Owner-Earnings

: 118.85 (As of Today)
View and export this data going back to 2005. Start your Free Trial

As of today (2024-04-19), DexCom's share price is $134.30. DexCom's Owner Earnings per Share (TTM) ended in Dec. 2023 was $1.13. It's Price-to-Owner-Earnings for today is 118.85.


The historical rank and industry rank for DexCom's Price-to-Owner-Earnings or its related term are showing as below:

DXCM' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 74.48   Med: 161.67   Max: 938.72
Current: 119.36

During the past 13 years, the highest Price-to-Owner-Earnings of DexCom was 938.72. The lowest was 74.48. And the median was 161.67.


DXCM's Price-to-Owner-Earnings is ranked worse than
86.69% of 278 companies
in the Medical Devices & Instruments industry
Industry Median: 30.8 vs DXCM: 119.36

As of today (2024-04-19), DexCom's share price is $134.30. DexCom's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.31. Therefore, DexCom's PE Ratio for today is 102.52.

As of today (2024-04-19), DexCom's share price is $134.30. DexCom's EPS without NRI for the trailing twelve months (TTM) ended in was $1.25. Therefore, DexCom's PE Ratio without NRI for today is 107.44.

During the past 13 years, DexCom's highest PE Ratio without NRI was 1031.29. The lowest was 61.17. And the median was 128.40.


DexCom Price-to-Owner-Earnings Historical Data

The historical data trend for DexCom's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 213.61 80.94 938.73 154.28 110.30

DexCom Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 154.28 122.55 127.74 91.20 110.30

Competitive Comparison

For the Medical Devices subindustry, DexCom's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DexCom Price-to-Owner-Earnings Distribution

For the Medical Devices & Instruments industry and Healthcare sector, DexCom's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where DexCom's Price-to-Owner-Earnings falls into.



DexCom Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

DexCom's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=134.30/1.13
=118.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DexCom  (NAS:DXCM) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


DexCom Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of DexCom's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


DexCom (DexCom) Business Description

Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Executives
Sadie Stern officer: Chief Human Resources Officer 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Steven R Altman director
Kevin R Sayer director
Jereme M Sylvain officer: SVP, Finance & CAO 6340 SEQUENCE DRIVE, SAN DIEGO X1 92121
Jacob Steven Leach officer: SVP, Research & Development 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Nicholas Augustinos director 754 GRAND VIEW AVENUE, SAN FRANCISCO CA 94114
Micheal Jon Brown officer: EVP, Chief Legal Officer 6340 SEQUENCE DR, SAN DIEGO CA 92121
Steven Robert Pacelli officer: Vice President Legal Affairs 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Girish Naganathan officer: EVP Chief Technology Officer C/O DEXCOM, INC., 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Barry J. Regan officer: EVP Operations 1023 CHERRY ROAD, MEMPHIS TN 38117
Bridgette P Heller director TECH DATA CORPORATION, 5350 TECH DATA DRIVE, CLEARWATER FL 33760
Matthew Vincent Dolan officer: * 6340 SEQUENCE DR, SAN DIEGO CA 92121
Rimma Driscoll director C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Shelly Ramasamy Selvaraj officer: SVP Information Technology 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Paul R Flynn officer: EVP, Global Revenue 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121